Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-22-012157
Filing Date
2022-11-08
Accepted
2022-11-08 13:30:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 29536
2 filename2.txt TEXT-EXTRACT 4232
  Complete submission text file 0000000000-22-012157.txt   45507
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filed for) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 6770 Blank Checks